Conexeu Sciences Inc. (CNXU) Stock
Healthcare · Biotechnology · Member of Other US Stocks
Conexeu Sciences Inc. (CNXU) closed at USD 3.65 on 2026-10-14, a change of -72.1 % over the past year, with a market capitalization of USD 111.42M.
Conexeu Sciences Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 3.65 |
| 2026-10-13 | 3.31 |
| 2026-10-12 | 3.77 |
| 2026-10-09 | 3.89 |
| 2026-10-08 | 3.45 |
| 2026-10-07 | 3.64 |
| 2026-10-06 | 3.66 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Conexeu Sciences Inc. key figures
- Previous close
- USD 3.65 (2026-10-14)
- 1-year change
- -72.1 %
- Market cap
- USD 111.42M
- Enterprise value
- USD 109.9M
- P/E ratio (trailing)
- -5.41
- P/E ratio (forward)
- -7.45
- EPS (trailing)
- -0.73
- EPS (forward)
- -0.53
- PEG ratio
- n/a
- Price to book
- 18.46
- Revenue growth
- n/a
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 0.97
- Employees
- n/a
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Conexeu Sciences Inc.
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Conexeu Sciences Inc. and compare it with other stocks.
Analyze CNXUAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Conexeu Sciences Inc. shares.